Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTERCEPT Fibrinogen Complex in Perioperative Bleeding
NCT05711524Phase 4Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Apr 2023
- Primary completion
- Oct 2024
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
- Countries
- 1
01
Overview
A Phase 4 trial of INTERCEPT Fibrinogen Complex in hypofibrinogenemia, hemorrhage, sponsored by Weill Cornell Medicine. Started Apr 2023; status: completed.
02
Drugs
INTERCEPT Fibrinogen Complex
03
Conditions
hypofibrinogenemiahemorrhage
Beyond the preview
Go deeper on NCT05711524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05711524.